125 related articles for article (PubMed ID: 11169925)
21. Strategies and methods in the identification of antagonists of protein-protein interactions.
Gadek TR
Biotechniques; 2003 Jun; Suppl():21-4. PubMed ID: 12813901
[TBL] [Abstract][Full Text] [Related]
22. [Multimeric receptors, new targets for the pharmaceutical industry].
Dutartre P
J Soc Biol; 2001; 195(4):437-42. PubMed ID: 11938562
[TBL] [Abstract][Full Text] [Related]
23. Cancer cell-based genomic and small molecule screens.
Caldwell JS
Adv Cancer Res; 2007; 96():145-73. PubMed ID: 17161679
[TBL] [Abstract][Full Text] [Related]
24. From combinatorial chemistry to cancer-targeting peptides.
Aina OH; Liu R; Sutcliffe JL; Marik J; Pan CX; Lam KS
Mol Pharm; 2007; 4(5):631-51. PubMed ID: 17880166
[TBL] [Abstract][Full Text] [Related]
25. Directed evolution and Phenomics screening of new biocatalysts.
Lefevre F; Ravot G; Nguyen HK; Ayrinhac C; Pallas S; Masson JM; Dupret D
Meded Rijksuniv Gent Fak Landbouwkd Toegep Biol Wet; 2001; 66(3a):249-56. PubMed ID: 15954596
[TBL] [Abstract][Full Text] [Related]
26. Protein-dependent ribozymes report molecular interactions in real time.
Hartig JS; Najafi-Shoushtari SH; Grüne I; Yan A; Ellington AD; Famulok M
Nat Biotechnol; 2002 Jul; 20(7):717-22. PubMed ID: 12089558
[TBL] [Abstract][Full Text] [Related]
27. Fluorescence-based methods for evaluating the RNA affinity and specificity of HIV-1 Rev-RRE inhibitors.
Luedtke NW; Tor Y
Biopolymers; 2003 Sep; 70(1):103-19. PubMed ID: 12925996
[TBL] [Abstract][Full Text] [Related]
28. Target-assisted iterative screening of phage surface display cDNA libraries.
Kurakin A; Wu S; Bredesen DE
Methods Mol Biol; 2004; 264():47-60. PubMed ID: 15020779
[TBL] [Abstract][Full Text] [Related]
29. The 7 TM G-protein-coupled receptor target family.
Jacoby E; Bouhelal R; Gerspacher M; Seuwen K
ChemMedChem; 2006 Aug; 1(8):761-82. PubMed ID: 16902930
[TBL] [Abstract][Full Text] [Related]
30. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.
Workman P
Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S45-56. PubMed ID: 12819933
[TBL] [Abstract][Full Text] [Related]
31. Directed evolution of PDZ variants to generate high-affinity detection reagents.
Ferrer M; Maiolo J; Kratz P; Jackowski JL; Murphy DJ; Delagrave S; Inglese J
Protein Eng Des Sel; 2005 Apr; 18(4):165-73. PubMed ID: 15820976
[TBL] [Abstract][Full Text] [Related]
32. Switch-peptides: design and characterization of controllable super-amyloid-forming host-guest peptides as tools for identifying anti-amyloid agents.
Camus MS; Dos Santos S; Chandravarkar A; Mandal B; Schmid AW; Tuchscherer G; Mutter M; Lashuel HA
Chembiochem; 2008 Sep; 9(13):2104-12. PubMed ID: 18683159
[TBL] [Abstract][Full Text] [Related]
33. Evaluating drug efficacy and toxicology in three dimensions: using synthetic extracellular matrices in drug discovery.
Prestwich GD
Acc Chem Res; 2008 Jan; 41(1):139-48. PubMed ID: 17655274
[TBL] [Abstract][Full Text] [Related]
34. Phenotypic screening of phylomer peptide libraries derived from genome fragments to identify and validate new targets and therapeutics.
Watt PM
Future Med Chem; 2009 May; 1(2):257-65. PubMed ID: 21425969
[TBL] [Abstract][Full Text] [Related]
35. Genetic interventions in mammalian cells; applications and uses in high-throughput screening and drug discovery.
Hampton SL; Kinnaird AI
Cell Biol Toxicol; 2010 Feb; 26(1):43-55. PubMed ID: 19904619
[TBL] [Abstract][Full Text] [Related]
36. Discovery of TNF inhibitors from a DNA-encoded chemical library based on diels-alder cycloaddition.
Buller F; Zhang Y; Scheuermann J; Schäfer J; Bühlmann P; Neri D
Chem Biol; 2009 Oct; 16(10):1075-86. PubMed ID: 19875081
[TBL] [Abstract][Full Text] [Related]
37. Large-scale functional analysis using peptide or protein arrays.
Emili AQ; Cagney G
Nat Biotechnol; 2000 Apr; 18(4):393-7. PubMed ID: 10748518
[TBL] [Abstract][Full Text] [Related]
38. High-throughput screening of historic collections: observations on file size, biological targets, and file diversity.
Spencer RW
Biotechnol Bioeng; 1998; 61(1):61-7. PubMed ID: 10099497
[TBL] [Abstract][Full Text] [Related]
39. Biotechnology techniques for the development of new tumor specific peptides.
Marr A; Markert A; Altmann A; Askoxylakis V; Haberkorn U
Methods; 2011 Nov; 55(3):215-22. PubMed ID: 21640826
[TBL] [Abstract][Full Text] [Related]
40. Combining Chemical Protein Synthesis and Random Nonstandard Peptides Integrated Discovery for Modulating Biological Processes.
Saha A; Suga H; Brik A
Acc Chem Res; 2023 Jul; 56(14):1953-1965. PubMed ID: 37312234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
